U.S. flag

An official website of the United States government

NM_000094.4(COL7A1):c.5701-1G>T AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Mar 29, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000498204.3

Allele description [Variation Report for NM_000094.4(COL7A1):c.5701-1G>T]

NM_000094.4(COL7A1):c.5701-1G>T

Gene:
COL7A1:collagen type VII alpha 1 chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_000094.4(COL7A1):c.5701-1G>T
HGVS:
  • NC_000003.12:g.48576558C>A
  • NG_007065.1:g.23695G>T
  • NM_000094.4:c.5701-1G>TMANE SELECT
  • LRG_286t1:c.5701-1G>T
  • LRG_286:g.23695G>T
  • NC_000003.11:g.48613991C>A
  • NM_000094.3:c.5701-1G>T
Links:
dbSNP: rs1553855868
NCBI 1000 Genomes Browser:
rs1553855868
Molecular consequence:
  • NM_000094.4:c.5701-1G>T - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000589630GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Pathogenic
(Feb 8, 2016)
germlineclinical testing

Citation Link,

SCV004292730Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Mar 29, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Epidermolysis bullosa pruriginosa: a case with a novel mutation and co-existent lichen amyloidosus.

Chen Q, Lee JS, Tey HL.

Indian J Dermatol Venereol Leprol. 2015 Jan-Feb;81(1):40-2. doi: 10.4103/0378-6323.148565.

PubMed [citation]
PMID:
25566895

Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages.

Vahidnezhad H, Youssefian L, Zeinali S, Saeidian AH, Sotoudeh S, Mozafari N, Abiri M, Kajbafzadeh AM, Barzegar M, Ertel A, Fortina P, Uitto J.

J Invest Dermatol. 2017 Mar;137(3):660-669. doi: 10.1016/j.jid.2016.10.023. Epub 2016 Oct 27.

PubMed [citation]
PMID:
27899325
See all PubMed Citations (5)

Details of each submission

From GeneDx, SCV000589630.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.5701-1 G>T pathogenic variant in the COL7A1 gene has been reported previously in association with RDEB(Chen et al., 2015). This splice site variant destroys the canonical splice acceptor site in intron 67. It is predicted tocause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNAdecay, or to an abnormal protein product if the message is used for protein translation. The c.5701-1 G>T variant wasnot observed in approximately 6500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. We interpret c.5701-1 G>T asa pathogenic variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004292730.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

Disruption of this splice site has been observed in individual(s) with autosomal dominant epidermolysis bullosa and/or autosomal recessive epidermolysis bullosa dystrophica (PMID: 25566895, 27899325). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 431992). This variant is also known as IVS67-1G>T. This variant is not present in population databases (gnomAD no frequency). This sequence change affects an acceptor splice site in intron 67 of the COL7A1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024